asked Her Majesty's Government:

In the light of the National Institute for Health and Clinical Excellence's recommendation that the newly developed inhaled insulin should not be available on the National Health Service, what assessment they have made of the needs of needle phobic diabetics.[HL6129]

A second appraisal committee decision on inhaled insulin from the National Institute for Health and Clinical Excellence (NICE) was published on21 June for consultation. The current appraisal committee decision includes proven injection phobia diagnosed by a psychiatrist or psychologist. However, this does not constitute NICE's formal guidance on this technology. The recommendations made are preliminary and may change after consultation.